Surgical management of collision-tumors between vestibular schwannoma and meningioma in the cerebellopontine angle in patients with neurofibromatosis type 2

被引:10
|
作者
Adib, Sasan Darius [1 ]
Tatagiba, M. [1 ]
机构
[1] Univ Tubingen, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany
关键词
Cerebellopontine angle; Collision tumor; Meningioma; Neurofibromatosis type 2; Vestibular schwannoma;
D O I
10.1007/s00701-019-03933-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionWhen vestibular schwannoma (VS) collides with meningioma at the cerebellopontine angle (CPA), a particular threat occurs. Sudden acceleration of tumor growth and unpredictable involvement of cranial nerves results in a special environment that aggravates management. The goal of this study was to analyze the extent of resection, postoperative facial and cochlear function, surgical strategy, and survival rates in patients with neurofibromatosis type 2 (NF2) with meningioma-vestibular schwannoma (M-VS) collision tumors.MethodsA total of 1284 VS, including 165 NF2 VS were operated at our department between January 2004 and May 2018. Out of these cases, a group of six NF2 patients with seven M-VS collision tumors was found following careful analysis of neuroradiological data and pathological and surgical reports. Patients were evaluated for extent of tumor resection and, furthermore, postoperative facial and hearing function.ResultsSix patients with NF2 with seven M-VS collision tumors were included in this study. Mean age was 328.2years. A gross total resection (GTR) of both colliding tumors was achieved in only one case, a GTR of the meningioma and a subtotal resection (STR) of the VS in four cases and in two cases only, the meningioma was removed. In five of the cases, facial function was intact or good (House and Brackmann grades I-II) at long-term follow-up (mean follow-up 22months). No mortality occurred during follow-up.Conclusions p id=Par4 Collision between M and VS at the CPA is a particular phenomenon in NF2 patients that may aggravate the situation with less favorable surgical outcome than NF-2 VS without meningioma.
引用
收藏
页码:1157 / 1163
页数:7
相关论文
共 50 条
  • [41] Phase II trial of icotinib in adult patients with neurofibromatosis type 2 and progressive vestibular schwannoma
    Zhao, Fu
    Li, Shi-wei
    Zhang, Shun
    Li, Peng
    Zhao, Chi
    Zhao, Xiao-bin
    Wang, Chun -Hong
    Zhang, Jing
    Wang, Bo
    Liu, Pi-nan
    JOURNAL OF NEUROSURGERY, 2023, 138 (06) : 1680 - 1687
  • [42] Hearing preservation surgery for neurofibromatosis type 2-related vestibular schwannoma in pediatric patients
    Slattery, William H., III
    Fisher, Laurel M.
    Hitselberger, William
    Friedman, Rick A.
    Brackmann, Derald E.
    JOURNAL OF NEUROSURGERY, 2007, 106 (04) : 255 - 260
  • [43] Long-Term Effects of Bevacizumab on Vestibular Schwannoma Volume in Neurofibromatosis Type 2 Patients
    Killeen, Daniel E.
    Klesse, Laura
    Tolisano, Anthony M.
    Hunter, Jacob B.
    Kutz, Joe Walter, Jr.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2019, 80 (05) : 540 - 545
  • [44] Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients
    Plotkin, Scott R.
    Merker, Vanessa L.
    Muzikansky, Alona
    Barker, Fred G., II
    Slattery, William, III
    OTOLOGY & NEUROTOLOGY, 2014, 35 (01) : E50 - E56
  • [45] Unilateral vestibular schwannoma with other neurofibromatosis Type 2-related tumors: clinical and molecular study of a unique phenotype
    Aghi, M
    Kluwe, L
    Webster, MT
    Jacoby, LB
    Barker, FG
    Ojemann, RG
    Mautner, VF
    MacCollin, M
    JOURNAL OF NEUROSURGERY, 2006, 104 (02) : 201 - 207
  • [46] Ipsilateral Cochlear Implantation After Cochlear Nerve Preserving Vestibular Schwannoma Surgery in Patients With Neurofibromatosis Type 2
    Lloyd, Simon Kingsley Wickham
    Glynn, Fergal John
    Rutherford, Scott Alexander
    King, Andrew Thomas
    Mawman, Deborah Jane
    O'Driscoll, Martin Paul
    Evans, Dafydd Gareth Richard
    Ramsden, Richard Thomas
    Freeman, Simon Richard Mackenzie
    OTOLOGY & NEUROTOLOGY, 2014, 35 (01) : 43 - 51
  • [47] Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients
    Aboukais, Rabih
    Baroncini, Marc
    Zairi, Fahed
    Bonne, Nicolas-Xavier
    Schapira, Stephane
    Vincent, Christophe
    Lejeune, Jean-Paul
    ACTA NEUROCHIRURGICA, 2013, 155 (05) : 771 - 777
  • [48] Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients
    Rabih Aboukais
    Marc Baroncini
    Fahed Zairi
    Nicolas-Xavier Bonne
    Stéphane Schapira
    Christophe Vincent
    Jean-Paul Lejeune
    Acta Neurochirurgica, 2013, 155 : 771 - 777
  • [49] Surgical Management of Peripheral Nerve Pathology in Patients With Neurofibromatosis Type 2
    Peyre, Matthieu
    Tran, Suzanne
    Parfait, Beatrice
    Bernat, Isabelle
    Bielle, Franck
    Kalamarides, Michel
    NEUROSURGERY, 2023, 92 (02) : 317 - 328
  • [50] MRI FLAIR Hyperintensity in Labyrinth is a Predictive Biomarker for Hearing Loss in Neurofibromatosis Type 2 Patients with Small Vestibular Schwannoma
    Walker, Robert L., III
    Mehta, Gautam
    Brewer, Carmen
    Asthagiri, Ashok
    Kim, Jeffrey
    Butman, John
    Chittiboina, Prashant
    JOURNAL OF NEUROSURGERY, 2017, 126 (04) : A1399 - A1399